Vivos Therapeutics, Inc.
VVOS
$4.20
-$0.40-8.70%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.01M | -3.86M | -2.83M | -2.62M | -1.93M |
| Total Depreciation and Amortization | 306.00K | 177.00K | 144.00K | 146.00K | 145.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 342.00K | 317.00K | 62.00K | 148.00K | 295.00K |
| Change in Net Operating Assets | 871.00K | -426.00K | -319.00K | -1.86M | -1.56M |
| Cash from Operations | -3.49M | -3.80M | -2.94M | -4.19M | -3.05M |
| Capital Expenditure | -771.00K | -122.00K | -165.00K | -192.00K | -60.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -5.14M | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -5.91M | -122.00K | -165.00K | -192.00K | -60.00K |
| Total Debt Issued | 9.64M | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.66M | -- | 3.50M | 4.30M | 7.50M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -837.00K | -- | -446.00K | -509.00K | -100.00K |
| Cash from Financing | 11.46M | -- | 3.05M | 3.79M | 7.40M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.06M | -3.92M | -51.00K | -592.00K | 4.29M |